KIT mutations and CD117 overexpression are markers of better progression-free survival in vulvar melanomas.
KIT mutations and CD117 overexpression are markers of better progression-free survival in vulvar melanomas. Br J Dermatol. 2017 Nov; 177(5):1376-1384.